Diabetes

Top Story

Adverse events decrease with DPP-IV, SGLT2 inhibitors in type 2 diabetes

March 29, 2017

The risks for all-cause mortality, cardiovascular disease and severe hypoglycemia are reduced for adults with type 2 diabetes prescribed DPP-IV inhibitors or the SGLT2 inhibitor dapagliflozin compared vs. insulin alone, study data from Sweden show.

Thomas Nyström, MD, of the unit for diabetes research, division of internal medicine, department of clinical science and education at the Karolinska Institute in Sweden, and colleagues evaluated data on adults with type 2 diabetes who filled a first-time prescription for a DPP-IV inhibitor or dapagliflozin (Farxiga, AstraZeneca), the only SGLT2 inhibitor available in Sweden during the study period (oral drug group, n = 10,879), or for insulin (insulin group, n = 10,879) between July 1, 2013, and Dec. 31, 2014, to determine the effect of the drugs on all-cause mortality, CVD and severe hypoglycemia. Median follow-up times were 1.51 years in the oral drug group and 1.53 years in the insulin group.

In the Journals

Type 1 diabetes associated with higher risk for ischemic, hemorrhagic stroke

March 23, 2017
Compared with the general population, patients with type 1 diabetes with or without maintaining target HbA1c levels were at increased risk for ischemic and hemorrhagic…
In the Journals Plus

Statin use increases type 2 diabetes risk

March 22, 2017
Adults treated with statin therapy are at higher risk for developing type 2 diabetes vs. those not prescribed statin therapy, according to a meta-analysis of…
Meeting News

EXCEL: PCI may be acceptable in patients with diabetes, less complex left main CAD

March 17, 2017
WASHINGTON, D.C. — Three-year data from the EXCEL trial indicate that PCI with an everolimus-eluting stent may be acceptable or even preferable to CABG for…
In the Journals Plus

Adverse events decrease with DPP-IV, SGLT2 inhibitors in type 2 diabetes

March 29, 2017
The risks for all-cause mortality, cardiovascular disease and severe hypoglycemia are reduced for adults with type 2 diabetes prescribed DPP-IV…

In the Journals

Type 1 diabetes associated with higher risk for ischemic, hemorrhagic stroke

March 23, 2017
Compared with the general population, patients with type 1 diabetes with or without maintaining target HbA1c levels were at increased risk for…

In the Journals Plus

Statin use increases type 2 diabetes risk

March 22, 2017
Adults treated with statin therapy are at higher risk for developing type 2 diabetes vs. those not prescribed statin therapy, according to a…

Meeting News

EXCEL: PCI may be acceptable in patients with diabetes, less complex left main CAD

March 17, 2017
WASHINGTON, D.C. — Three-year data from the EXCEL trial indicate that PCI with an everolimus-eluting stent may be acceptable or even preferable…

AMA, ACS, AHA, ADA to Congress: Slow down, reconsider AHCA

March 17, 2017
At a recent National Press Club event, the AMA, American Cancer Society Cancer Action Network, American Diabetes Association and American Heart…

In the Journals

ADA recommends metformin to treat type 2 diabetes

March 13, 2017
Annals of Internal Medicine today published a synopsis focusing on the updated 2017 American Diabetes Association Standards of Medical Care in…

In the Journals Plus

Vildagliptin, metformin increase heart rate after meals in type 2 diabetes

March 9, 2017
The DPP-IV inhibitor vildagliptin and metformin may both lead to an increased heart rate after eating in adults with type 2 diabetes, but the agents…

Meeting News

Gluten-free diets may be linked to increased type 2 diabetes risk

March 9, 2017
Frequent consumption of gluten may be associated with a lower risk for type 2 diabetes, according to research presented at the American Heart…

In the Journals Plus

Diabetes increases all-cause mortality risk in chronic heart failure

March 8, 2017
Adults with chronic heart failure and diabetes have higher risks for all-cause death, cardiovascular death and hospitalization for worsening heart…

In the Journals Plus

Probiotic supplementation may reduce hypertension, dyslipidemia in type 2 diabetes

March 8, 2017
Adults with type 2 diabetes randomly assigned to probiotic supplementation saw a small reduction in blood pressure, total cholesterol, LDL…

More Headlines »
Advertisement
Advertisement